| Financial Year |
March 31 2023 |
| Monetary Funds |
1,026,465,462.87 |
| Held-for-trading Financial Assets |
18,150,446.15 |
| Notes Receivable |
177,320,530.52 |
| Accounts Receivable |
4,150,306,038.51 |
| Advances to Suppliers |
46,608,238.21 |
| Other Receivables |
73,379,746.86 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,471,835,104.08 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,213,185,738.26 |
| Total Current Assets |
10,592,276,045.79 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
2,456,140.90 |
| Long-term Equity Investment |
316,098,852.71 |
| Investment Properties |
-- |
| Fixed Assetes |
1,683,498,875.93 |
| Under-construction Projects |
259,691,097.72 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
415,421,336.78 |
| R&D expenses |
-- |
| Goodwill |
7,383,853.45 |
| Long-Term Deferred and Prepaid Expenses |
104,324,691.38 |
| Deferred Income Tax Assets |
119,987,862.10 |
| Other Non-Current Assets |
302,834,090.83 |
| Sub-Total of Non-Current Assets |
3,787,758,187.14 |
| Total Assets |
14,380,034,232.93 |
| Short-Term Loans |
491,857,438.07 |
| Trading Financial liabilities |
1,013,500.00 |
| Notes Payable |
1,579,933,798.46 |
| Accounts Payable |
2,704,561,349.50 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
484,973,591.57 |
| Taxes Payable |
53,624,549.15 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
430,050,540.80 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
45,166,152.75 |
| Other Current Liabilities |
9,494,380.85 |
| Sub-Total of Current Liabilities |
6,170,874,173.38 |
| Long-term Loans |
814,213,698.25 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
328,504,553.19 |
| Deferred Income Tax Liabilities |
3,502,417.50 |
| Other Non-Current Liabilities |
627,099.59 |
| Sub-Total of Non-Current Liabilities |
1,292,212,311.81 |
| Total Liabilities |
7,463,086,485.19 |
| Paid-In Capital(Or Share Stock) |
555,198,000.00 |
| Capital Surplus |
2,525,280,198.25 |
| Surplus Reserve |
277,637,000.00 |
| LESS:Treasury Stock |
247,344,285.00 |
| Undistributed Profits |
3,613,720,615.25 |
| Minority Stockholder's Interest |
66,178,013.20 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,850,769,734.54 |
| Owner's Equity（Stockholder's Equity） |
6,916,947,747.74 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
14,380,034,232.93 |
